TotalMarketCap

Ardelyx

ARDXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$750.347 M

$2.99 -9.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Ardelyx (ARDX) has a market capitalization of $750.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$407.3M

#1997 by revenue

Earnings

-$62.0M

Loss-making

Shares outstanding

251,372,553

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #161AlumisALMS$756.5M
  2. #162AnnexonANNX$755.5M
  3. #163ArdelyxARDX$750.3M
  4. #164Lexicon PharmaceuticalsLXRX$723.1M
  5. #165Ironwood PharmaceuticalsIRWD$657.7M

What if Ardelyx were worth as much as…

Open the what-if tool →

Gold $28.2T

$112,330.78

Per share 37,632× higher

Bitcoin $1.53T

$6,078.02

Per share 2,036× higher

Apple $5.02T

$19,953.58

Per share 6,685× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Ardelyx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.